These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11137563)

  • 41. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
    Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines.
    Laurençot CM; Scheffer GL; Scheper RJ; Shoemaker RH
    Int J Cancer; 1997 Sep; 72(6):1021-6. PubMed ID: 9378536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance.
    Dhar S; Nygren P; Liminga G; Sundström C; de la Torre M; Nilsson K; Larsson R
    Eur J Pharmacol; 1998 Apr; 346(2-3):315-22. PubMed ID: 9652375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of MDR antagonists on the cidal activity of vincristine for cells expressing MDR-1 is superior to those expressing MRP.
    Hosoi E; Hirose M; Hamano S; Morimoto M; Kuroda Y
    Int J Oncol; 1998 Aug; 13(2):343-8. PubMed ID: 9664131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.
    Lopes EC; Scolnik M; Alvarez E; Hajos SE
    Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab-induced inhibition of YY1 and Bcl-xL expression in Ramos non-Hodgkin's lymphoma cell line via inhibition of NF-kappa B activity: role of YY1 and Bcl-xL in Fas resistance and chemoresistance, respectively.
    Vega MI; Jazirehi AR; Huerta-Yepez S; Bonavida B
    J Immunol; 2005 Aug; 175(4):2174-83. PubMed ID: 16081784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
    Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The multidrug resistance phenotype confers immunological resistance.
    Weisburg JH; Curcio M; Caron PC; Raghu G; Mechetner EB; Roepe PD; Scheinberg DA
    J Exp Med; 1996 Jun; 183(6):2699-704. PubMed ID: 8676093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
    Draper MP; Martell RL; Levy SB
    Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth inhibitory effects of paclitaxel on human epithelioid sarcoma in vitro: heterogeneity of response and the multidrug resistance phenotype.
    Reinecke P; Knopf C; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
    Cancer; 2000 Apr; 88(7):1614-22. PubMed ID: 10738220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug resistance-associated protein (MRP) in haematological malignancies.
    Nooter K; Burger H; Stoter G
    Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
    Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
    Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of P-glycoprotein-mediated multidrug resistance in a doxorubicin-resistant subline of the human lymphoblastoid cell line CCRF-CEM by phosphorothioate antisense oligonucleotides.
    Dassow H; Lassner D; Remke H; Preiss R
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):93-6. PubMed ID: 9520155
    [No Abstract]   [Full Text] [Related]  

  • 56. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines].
    Matsumoto Y; Matsumoto M; Minemura M; Takano H; Nagao S; Iglesias A; Fojo T
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1941-6. PubMed ID: 9350240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells.
    Noskova V; Dzubak P; Kuzmina G; Ludkova A; Stehlik D; Trojanec R; Janostakova A; Korinkova G; Mihal V; Hajduch M
    Neoplasma; 2002; 49(6):418-25. PubMed ID: 12584592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.
    Nielsen D; Eriksen J; Maare C; Litman T; Kjaersgaard E; Plesner T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):363-70. PubMed ID: 10856431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemoimmunosensitization of the T24 human bladder cancer line to Fas-mediated cytotoxicity and apoptosis by cisplatin and 5-fluorouracil.
    Mizutani Y; Wu XX; Yoshida O; Shirasaka T; Bonavida B
    Oncol Rep; 1999; 6(5):979-82. PubMed ID: 10425290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.